Form 8-K - Current report:
SEC Accession No. 0001641172-25-024036
Filing Date
2025-08-14
Accepted
2025-08-14 16:15:50
Documents
16
Period of Report
2025-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41754
2 EX-99.1 ex99-1.htm EX-99.1 93219
3 GRAPHIC ex99-1_001.jpg GRAPHIC 15852
4 GRAPHIC ex99-1_002.jpg GRAPHIC 19042
  Complete submission text file 0001641172-25-024036.txt   406587

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE biaf-20250814.xsd EX-101.SCH 3784
6 XBRL DEFINITION FILE biaf-20250814_def.xml EX-101.DEF 26625
7 XBRL LABEL FILE biaf-20250814_lab.xml EX-101.LAB 36672
8 XBRL PRESENTATION FILE biaf-20250814_pre.xml EX-101.PRE 25249
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5815
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 251219359
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)